Abstract

An imbalance of TNF signalling in the inflammatory milieu generated by meningeal immune cell infiltrates in the subarachnoid space in multiple sclerosis (MS), and its animal model may lead to increased cortical pathology. In order to explore whether this feature may be present from the early stages of MS and may be associated with the clinical outcome, the protein levels of TNF, sTNF-R1 and sTNF-R2 were assayed in CSF collected from 122 treatment-naïve MS patients and 36 subjects with other neurological conditions at diagnosis. Potential correlations with other CSF cytokines/chemokines and with clinical and imaging parameters at diagnosis (T0) and after 2 years of follow-up (T24) were evaluated. Significantly increased levels of TNF (fold change: 7.739; p < 0.001), sTNF-R1 (fold change: 1.693; p < 0.001) and sTNF-R2 (fold change: 2.189; p < 0.001) were detected in CSF of MS patients compared to the control group at T0. Increased TNF levels in CSF were significantly (p < 0.01) associated with increased EDSS change (r = 0.43), relapses (r = 0.48) and the appearance of white matter lesions (r = 0.49). CSF levels of TNFR1 were associated with cortical lesion volume (r = 0.41) at T0, as well as with new cortical lesions (r = 0.56), whilst no correlation could be found between TNFR2 levels in CSF and clinical or MRI features. Combined correlation and pathway analysis (ingenuity) of the CSF protein pattern associated with TNF expression (encompassing elevated levels of BAFF, IFN-γ, IL-1β, IL-10, IL-8, IL-16, CCL21, haptoglobin and fibrinogen) showed a particular relationship to the interaction between innate and adaptive immune response. The CSF sTNF-R1-associated pattern (encompassing high levels of CXCL13, TWEAK, LIGHT, IL-35, osteopontin, pentraxin-3, sCD163 and chitinase-3-L1) was mainly related to altered T cell and B cell signalling. Finally, the CSF TNFR2-associated pattern (encompassing high CSF levels of IFN-β, IFN-λ2, sIL-6Rα) was linked to Th cell differentiation and regulatory cytokine signalling. In conclusion, dysregulation of TNF and TNF-R1/2 pathways associates with specific clinical/MRI profiles and can be identified at a very early stage in MS patients, at the time of diagnosis, contributing to the prediction of the disease outcome.

Highlights

  • TNF is one of the main inflammatory mediators involved in several pathological conditions, including chronic inflammatory diseases such as multiple sclerosis (MS)

  • By performing pathway analysis of the cerebrospinal fluid (CSF) inflammatory patterns associated with TNF or TNF-R1/2 expression, we found that the TNF-associated profile encompassed the highest number of canonical pathways (n = 66) compared to the soluble TNF (sTNF)-R1 and sTNF-R2 patterns (n = 35 and n = 38, respectively; Figure 3a,b)

  • Our study confirms that TNF is significantly elevated in the CSF of MS patients at the time of diagnosis and that soluble TNF-R1 predominates over TNF-R2 even in physiological conditions (5:1 ratio) with a greater overexpression of TNF-R1 in patients compared to controls

Read more

Summary

Introduction

TNF is one of the main inflammatory mediators involved in several pathological conditions, including chronic inflammatory diseases such as multiple sclerosis (MS). TNF can be produced by several cell types, including immune cells (macrophages and T cells) as well as central nervous system (CNS) cells (astrocytes and microglia) It plays a pivotal role in many aspects of immune system development, immune response regulation and T cell-mediated tissue injury [1], and may have both pro-inflammatory and immuneregulatory properties, influencing the generation of the T cell repertoire, antigen-presenting cell function and apoptosis of potentially autoreactive T cells [2]. These two different effects are related to the activation of different inflammatory signalling pathways after binding to the two different receptors: TNF-R1 and TNF-R2. TNF-R1 expression can be induced in several cell types and activated by both mTNF and sTNF, while TNF-R2 is restricted to endothelial cells, various immune cells and certain CNS cells and can be effectively stimulated by mTNF [4,5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call